3646 results for «504»

Filter By

3646 results

Clinical cases - Coronary interventions - Session 8

07 Oct 2022 – From AICT-AsiaPCR 2022

Top cases of AICT-AsiaPCR 2023

21 Sep 2023 – From AICT-AsiaPCR 2023

Discover the most intriguing cases featured at AICT-AsiaPCR 2023 in this session: from adrenaline surges to complex primary PCIs gone haywire, from CHIP protected PCI in AMICS to complex CTO of an anomalous RCA, dive into these real-world cases and gain valuable insights that expand your...

Top cases of AICT-AsiaPCR 2023

Learning - Percutaneous management of pulmonary embolism

22 Sep 2023 – From AICT-AsiaPCR 2023

Consult this session on percutaneous management of pulmonary embolism to learn about the indications for percutaneous pulmonary thrombectomy, to discover the techniques for performing this procedure, to gain insights into the various devices available, while exploring real-world case studies and staying updated on the latest clinical...

Learning - Percutaneous management of pulmonary embolism

Imaging solutions and innovative techniques in bifurcation lesions

22 Sep 2023 – From AICT-AsiaPCR 2023

Explore the complexities of bifurcation lesions through these presentations: learn how imaging can unravel the mysteries of ostial circumflex disease in previously stented LAD cases, discover innovative techniques, from DK crush to mini-culotte, in managing bailout double bifurcation scenarios, dive deep into the intricacies of jailed...

Imaging solutions and innovative techniques in bifurcation lesions

EuroPCR 2025 – The FAITAVI trial: angiography versus physiology-guided PCI in patients undergoing TAVI – 12-month follow-up data

21 May 2025

Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were selected because of their design, results, and potential to impact practice, among them is the...

EuroPCR 2025 – The FAITAVI trial: angiography versus physiology-guided PCI in patients undergoing TAVI – 12-month follow-up data

ENVISAGE-TAVI AF: edoxaban vs. vitamin K antagonists after TAVI in patients with atrial fibrillation

31 Aug 2021

Following the Hot Line session of the ESC Congress 2021 presented by George Dangas (New-York, USA), Daniele Giacoppo offers us a condensed version of this study.

Daniele Giacoppo

Author

Daniele Giacoppo
ENVISAGE-TAVI AF: edoxaban vs. vitamin K antagonists after TAVI in patients with atrial fibrillation
Didn’t find what you were looking for?